Logo

WORKING PARTY ON DESMOPRESSIN IN THE MANAGEMENT
OF VON WILLEBRAND DISEASE:
BIOLOGICAL RESPONSE VERSUS CLINICAL EFFICACY
A WORLD WIDE PROSPECTIVE OBSERVATIONAL STUDY
(On behalf of the ISTH –SSC on VWF and AICE)


LOGIN

A Working Party on Desmopressin in the management of von Willebrand Disease (DDAVP-IN-VWD) has been organized on behalf of the Scientific Sub-Committee on von Willebrand Factor of the International Society of Thrombosis and Haemostasis (ISTH-SSC on VWF) and of the Italian Association of Hemophilia Centers (AICE). Aims of this Working Party are to evaluate the clinical efficacy of Desmopressin (DDAVP) in type 1 and 2 VWD patients followed by large number of Hemophilia Centers in a prospective observational study organized world wide.

Members of the Steering Committee of this WP are: Augusto B. Federici, Christine A. Lee, Stefan Lethagen (Coordinators); Victor Blanchette, Mariana Bonduel, Giancarlo Castaman, Alice Cohen, Elbio D' Amico, Craig K. Kessler, David Lillicrap, Robert R. Montgomery, Barbara M. Zieger (Members)

For any further information, please contact the Coordinators.
On behalf of the other Members:



Augusto B. Federici, MD
Associate Professor of Hematology
Angelo Bianchi Bonomi
Hemophilia Thrombosis Center
Department of Internal Medicine
University of Milan
Via Pace 9, 20122 Milan, Italy
Tel + 39 02 55 03 53 56
Fax + 39 02 55 03 53 47
augusto.federici@unimi.it
This web-site has been realized with the support of  

Prospective observational study on DDAVP in Von Willebrand disease patients
Contact Webmaster webmaster@ddavp-in-vwd.com